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BACKGROUND: Completeness of ascertainment is a very important aspect of cancer registration. There is no recent published estimate
for childhood cancer in Britain.
METHODS: We estimated completeness of ascertainment by the National Registry of Childhood Tumours for cancer diagnosed under
age 15 years in residents of Britain during 2003–04. Stratified two-source capture-recapture was applied to notifications from general
cancer registries (CRs) and specialist clinicians. Variation in notification patterns was assessed by logistic regression. Results were verified
by cross-checking with Hospital Episode Statistics for leukaemia patients from England born in 1998 and diagnosed before 2005.
RESULTS: CRs notified 92–96% of registrations, and specialist clinicians 93%. Notification patterns varied slightly according to registry
region, age at diagnosis, diagnostic group, socioeconomic status, and whether the patient had died. Irrespective of stratification by these
factors, the overall completeness estimate was 99–100% (assuming independence of sources). Estimated completeness was at least
99% within all subgroups, except for one region (Thames 98–99%) and two small diagnostic groups (germ-cell and gonadal cancer
98–99%, melanoma and non-skin cancer 97–98%).
INTERPRETATION: The independence assumption cannot be fully justified, as both sources used records from treatment centres. With this
caveat, ascertainment of recently diagnosed childhood cancer in Britain appears to be virtually complete.
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In calculating cancer incidence and survival rates from population-
based cancer registry data, completeness of ascertainment of cases
is very important. In Britain there is a special registration process
for cancer in children, which may differ in completeness from the
equivalent process in adults.
Cancer registry completeness can be evaluated by independent
case ascertainment, capture-recapture, or death-certificate meth-
ods (Parkin and Bray, 2009). Methods involving death certificates
are difficult to apply to childhood cancer, because the proportion
of patients who die within a few years of diagnosis is much lower
than for adults. A simple form of capture-recapture, stratifying for
factors that may affect the probability of notification (Hook and
Regal, 1995), is appropriate for the National Registry of Childhood
Tumours (NRCT), as there are two principal sources of notifica-
tion. The national Hospital Episode Statistics (HES) database
provides a separate list of cases for cross-checking.
Two-source capture-recapture was previously used to estimate
completeness of ascertainment by the NRCT for childhood
leukaemia and non-Hodgkin lymphoma diagnosed during 1966–
1983 (Draper et al, 1991). We are not aware of any other published
estimate of completeness of national cancer registration in Britain
specifically for children. Capture-recapture has been used to
estimate completeness of ascertainment of childhood cancers in
New Zealand for the diagnosis period 1990–1993 (Dockerty et al,
1997) and of childhood acute leukaemia in three cities in Brazil
during 2001 (Azevedo-Silva et al, 2009).
A comprehensive literature review reported that records-based
studies of childhood leukaemia incidence generally found a
positive association with higher socioeconomic status (SES) (Poole
et al, 2006). More recently, for the lymphoid subgroup in
particular (the majority of childhood leukaemia in developed
countries, peaking at ages 2–3 years) a similar association has
been reported for children in the USA (Adelman et al, 2007) and
England and Wales (Stiller et al, 2008), at ages 0–4 and 1–4 years
respectively. One possible explanation is that ascertainment might
be less complete for children of lower SES. It has also been
suggested that, for cancer at any age, completeness may vary
between registry regions of England and Wales (Quinn et al, 2001).
In this paper we estimate recent completeness of ascertainment of
childhood cancers in Britain, and investigate some factors that might
affect the probability of notification: registry region of residence, age
at diagnosis, diagnostic group, whether the patient had died, and (in
England and Wales) SES. The results should aid the interpretation of
population-based studies of childhood cancer in Britain.
MATERIALS AND METHODS
Materials
Cancer registration in the UK relies mainly on routine medical and
administrative records from National Health Service (NHS)
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yhospitals where cancer is diagnosed and treated, supplemented by
notifications derived from death certificates mentioning cancer.
The system operates through a network of general cancer registries
(CRs), which has covered the whole geographical area of Britain
(England, Wales and Scotland) since 1962. Currently there are 11
CR zones for the UK, comprising Northern Ireland, Scotland,
Wales, and eight regions of England. The NRCT exists to give
special attention to cases diagnosed under the age of 15 years.
The NRCT matches and amalgamates notifications from two
principal sources: first the CRs, described above, and second a
register of patients seen by clinicians affiliated to the Children’s
Cancer and Leukaemia Group (CCLG) (until 1 August 2006, the
United Kingdom Children’s Cancer Study Group (UKCCSG)), the
organisation that co-ordinates paediatric oncology in the UK and
Eire. The NRCT also receives copies of death certificates with
neoplasm given as the underlying cause for deaths occurring in
Britain under the age of 20 years. In the very rare event that a valid
death-certificate notification is not ascertained through another
source, the case is registered and the date of death is used in place
of the date of diagnosis.
Registered patients for whom a death certificate has not been
received within 3 years of diagnosis are submitted for tracing and
flagging on the NHS Central Registers for England, Wales and
Scotland, so that embarkation, death and subsequent primary
cancer can be ascertained. Further information is obtained from
specialist childhood cancer registries within three of the eight
English regions (North West, Northern/Yorkshire and West
Midlands) and, for leukaemia patients only, from registers of
participants in national clinical trials supported by the Medical
Research Council. For patients notified by the CCLG, the accuracy
of the information held by the NRCT is verified and updated
through a series of routine follow-up enquiries to the notifying
clinicians. The diagnostic codes provided on death certificates and
on pathology reports (included with most CCLG notifications) are
checked against the description in words, by a medically qualified
member of staff. The coding system is standardised and
periodically updated. Currently, all cases are coded to the site
and type codes of the third edition of the International
Classification of Diseases for Oncology (ICD-O), and hence to
the third edition of the International Classification of Childhood
Cancer (ICCC3) (Steliarova-Foucher et al, 2005).
After processing, registrations are notified by the NRCT to the
general cancer registration system: retrospectively in February
2006 for cases diagnosed during 1981–2002, and prospectively
since February 2007 through quarterly data exchange with the CRs.
Methods
Data definitions We examined registration of cancer diagnosed
between 1 January 2003 and 30 December 2004 in children aged
under 15 years who were resident in England, Wales or Scotland.
‘Cancer’ was defined as in ICCC3, and included intracranial and
intraspinal (CNS) tumours of benign and uncertain behaviour. We
excluded skin carcinoma (which is relatively rare in children)
because these cases might not have been systematically registered
(Goodwin et al, 2004), and non-CNS disease classified as non-
malignant in previous standard coding systems. We assessed
notifications received from the two principal sources of ascertain-
ment to the NRCT: the CRs and the CCLG register (including its
predecessor, the UKCCSG register). The two eligible cases
ascertained only by death certificate were treated as CR notifica-
tions.
The NRCT had received all routine notifications for the study
period by February 2007, when quarterly data exchange with the
CRs began. Further information received by April 2009 included
some notifications from CRs for previously CCLG-only cases. As
these notifications could have been feedback of data originally
received from the CCLG and notified to the CRs by the NRCT,
analyses were performed under the extreme assumptions that
either (A) all or (B) none were feedback. In both versions we took
all other notifications as they were in April 2009.
Capture-recapture estimates of completeness We used two-source
capture-recapture to estimate the number of cases in the
population, and hence the fraction registered (completeness).
The nearly unbiased estimator of the number of cases in
the population is defined as aþbþcþ((b c)/(aþ1)), where a
is the number of registrations notified both by the first and by the
second source, b by the first source only, and c by the second
source only, on the assumptions that, for each source, every case
has the same probability of ascertainment, and that ascertainment
of any case by one source is independent of ascertainment by the
other (Hook and Regal, 1995).
We used stratification to adjust for variation in factors that
might affect the probability of ascertainment. For children living in
England, Wales and Scotland at diagnosis, we grouped the
registrations by CR zone (the CR responsible for the address at
which the child lived at the time of diagnosis, irrespective of
whether the CR actually notified the case or not), by age at
diagnosis (0, 1–4, 5–9 and 10–14 completed years), by the 12
main diagnostic groups defined by the first level of ICCC3
(Steliarova-Foucher et al, 2005), and by whether the child had died
or not, as known to the NRCT in April 2009. For each factor, the
stratified estimate of completeness was the overall number of
registrations divided by the sum of the separate capture-recapture
estimates for the number of cases in the population within each
stratum.
For children living in England and Wales at diagnosis, we
investigated the possibility that ascertainment might be less
complete for patients of lower SES. From the Office for National
Statistics we obtained the Carstairs deprivation index (Carstairs
and Morris, 1989) for census wards in England and Wales in 2001
(Morgan and Baker, 2006). We grouped the census wards into
quintile categories of the Carstairs index, each containing
approximately the same number of children aged 0–14, using
2001 census population counts (Office for National Statistics,
2010a). We allocated each registration to the census ward that
included the postcode of residence at diagnosis (Office for
National Statistics, 2010b), and took the Carstairs quintile category
number of that census ward as a measure of SES for the case
(1¼least deprived, 5¼most deprived). We grouped the registra-
tions as lymphoid leukaemia (ICCC3 site group I, subgroup a),
leukaemia (ICCC3 site group I), CNS tumours (ICCC3 site group
III), and non-CNS solid cancers except skin carcinomas (the
remainder). We calculated a separate capture-recapture estimate
for cases in each SES category within each diagnostic group. For
lymphoid leukaemia, we repeated this analysis by age group.
Notification patterns We used logistic regression models to
investigate whether the proportion of cases notified by only one
source varied with the factors used for stratification. We
successively defined an ‘event’ as a registration being CR-only,
or CCLG-only under feedback assumption (A), or CCLG-only
under feedback assumption (B). For factors other than SES, we
performed likelihood ratio tests for heterogeneity in the odds of an
event, for strata in which there was at least one event. For SES, we
performed likelihood ratio tests for trend in the odds of an event,
within age-diagnosis groups containing at least 10 events. All tests
were at the 5% significance level. Calculations were done in Stata
version 11 (StataCorp, 2009).
Cross-check with Hospital Episode Statistics The completeness
estimates for childhood leukaemia were verified by a cross-check
with HES. Leukaemia was chosen because (a) this is a large and
relatively homogeneous group of diseases, (b) treatment usually
involves many in-patient episodes, (c) the peak age at diagnosis is
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from birth spanned by the available HES data, and (d) complete-
ness of ascertainment is of particular interest because of the
positive association of recorded incidence with higher SES
previously reported in NRCT data for lymphoid leukaemia in
age group 1–4 years (Stiller et al, 2008).
The national HES database provided an electronic record of
in-patient episodes since April 1997 at NHS-funded treatment
centres in England for patients resident anywhere, or in Wales for
residents of England only. No names were supplied, but each
episode was marked with an identification number (ID) that had
been defined automatically by HES from the available data.
Various diagnosis codes were supplied for each episode, recording
the clinical picture at the time of the episode, which was not
necessarily a definitive diagnosis.
We assumed that all episodes with the same ID belonged to the
same patient. However, we did not assume that all distinct IDs
necessarily represented distinct patients, because it was possible
that the identification data recorded for any individual patient
might vary between episodes, due to change, error or omission.
We selected episodes that included a leukaemia diagnosis (ICD-
10 C91 to C95) and that recorded the birth year as 1998. We
grouped these episodes by ID, and selected IDs whose first
leukaemia episode was before the end of 2004, so that any
diagnosis made before the sixth birthday should be included.
Where possible, the IDs were automatically matched with NRCT
cases, by either the NHS number or the combination of date of
birth, sex, and postcode. We manually checked the unmatched IDs.
We also checked the matched NRCT case children who according
to the NRCT had a non-leukaemia diagnosis, were not born in
1998, or were not resident in England at diagnosis.
RESULTS
Notification patterns and capture-recapture estimates of
completeness
Of the 2985 registrations for patients resident in England, Wales
and Scotland at diagnosis, 206 (7%) were notified only by the CRs,
and between 117 (4%) and 224 (8%) were notified only by the
CCLG (Table 1). The number of CCLG-only notifications depended
on the extent to which CR notifications received after February
2007 for previously CCLG-only cases were the result of feedback;
the reported range represents the extreme possibilities that none
(under assumption (B)) or all (under (A)) were feedback. The
overall capture-recapture completeness estimate was 99% under
assumption (A) and 100% under (B). Results stratified by CR zone,
age group, diagnostic group, or whether the child had died, were
very close to the crude estimate.
The percentage of CR-only notifications varied between registry
zones (Po0.001), ranging from 2% in Mersey and the West
Midlands to 22% in Wales. The percentage of CCLG-only
notifications also varied between zones (Po0.001), and was
highest in Eastern (10%) or Thames (6–18%), depending on the
feedback assumption. The CCLG-only percentage was very low in
Wales and the South West, West Midlands, and Oxford regions,
suggesting that in these areas there may have been direct transfer
of data from the local CCLG centre to the CR before the data were
supplied to the NRCT. Excluding these four zones, and assuming
feedback, the proportion notified by the CRs may have been as low
as 1844 (90%) of 2054 registrations. The completeness estimates
were 98–99% in Thames, 99% in Eastern, 99–100% in Scotland,
and 100% elsewhere.
The percentage of CR-only notifications ranged from 4% in age
group 1–4 to 11% in age group 10–14 years (Po0.001). Under
feedback assumption (A), the CCLG-only percentage ranged from
6% in age group 10–14 years to 12% at age under 1 year
(P¼0.012). Under assumption (B), CCLG-only notification did not
vary by age, the percentage being 3–5% in all age groups. The
completeness estimate was 99–100% in age groups under 1 year
and 10–14 years, and 100% at other ages.
CR-only notification varied between diagnostic groups
(Po0.001), ranging from 0–3% for leukaemia, neuroblastoma,
retinoblastoma and renal/hepatic cancers, to 14% for germ-cell/
gonadal cancers, 39% for melanoma/carcinoma (i.e., malignant
melanoma and non-skin carcinoma not included in other groups),
and 78% for other/unspecified cancer (from only 23 registrations).
Under feedback assumption (A), the percentage of CCLG-only
notifications varied between diagnostic groups, ranging from 0%
for hepatic cancer to 17% for retinoblastoma (P¼0.036). Under
assumption (B), the percentage of CCLG-only notifications did not
significantly vary with diagnosis, the largest being 11% for
retinoblastoma. The completeness estimate was 100% for leukae-
mia, neuroblastoma, retinoblastoma and renal/hepatic cancers,
99–100% for lymphoma, CNS tumours, bone cancer and soft-
tissue sarcoma, 98–99% for germ-cell/gonadal cancer, 97–98% for
melanoma/carcinoma, and 86% (from 23 registrations) for other/
unspecified cancer.
The CR-only percentage was 5% for children who had died and
7% for other children (P¼0.029). Under feedback assumptions
(A) and (B), the CCLG-only percentage was respectively 2–5% for
those who had died and 4–8% for others (Po0.001 and P¼0.005).
The completeness estimate was 100% for children who had died,
and 99–100% for other children.
Among children resident in England and Wales at diagnosis,
there was some variation with SES in notification patterns
(Table 2). For CNS tumours, there was a decreasing trend with
deprivation in CR-only notification (P¼0.035); the percentage was
2% in the most deprived quintile, and 6–10% elsewhere. For
leukaemia, under feedback assumption (A) only, there was an
increasing trend with deprivation in CCLG-only notification
(P¼0.007); the percentage was 16% in the most deprived quintile,
and 7–8% elsewhere. There was a similar pattern in the lymphoid
subgroup (P¼0.021, Table 2), which was not statistically
significant when subdivided into age groups (Table 3). There
was no evidence for trends under feedback assumption (B). For
CNS tumours, leukaemia and lymphoid leukaemia, the complete-
ness estimate was 100% in all five deprivation categories, under
both feedback assumptions (Table 2); for lymphoid leukaemia by
age group it was lower (98–99%) in the least deprived category for
age group 10–14 only (Table 3). For non-CNS solid cancer, the
completeness estimate was 99% in the most deprived category, and
99–100% elsewhere (Table 2).
Cross-check with Hospital Episode Statistics
There were 432 different IDs in the HES file, of which 390 (90%)
were automatically matched to 297 NRCT cases (on NHS number
or the combination of date of birth, sex, and postcode), confirming
that distinct IDs did not necessarily represent distinct patients. Of
the 42 unmatched IDs, 31 had five or fewer leukaemia episodes,
and 21 had only one. None of the episodes for these IDs recorded a
death, and identifying information was often incomplete. Group-
ing by birthdate, sex, postcode and NHS number, as available,
reduced the 42 unmatched IDs to 26 probably distinct patients.
Comparing birthdate, sex, diagnosis, and episode dates, nine of
these patients appeared to be possible matches for NRCT cases that
had been linked to other IDs in the HES file, and four were definite
matches for cases that were known to be ineligible for the NRCT.
Two patients, with 37 and 44 episodes, respectively, were traced by
enquiry at the relevant treatment centres, and were both
found to be ineligible for the NRCT because they were not
resident in the UK at diagnosis. Checking the full HES database,
four patients (accounting for eight leukaemia episodes altogether)
appeared to have a haematological but non-leukaemic diagnosis.
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unidentified treatment fragments or errors, as they accounted for
only 11 leukaemia episodes altogether.
Of the 297 NRCT cases that were matched to one or more of the
390 HES IDs, 269 were leukaemia patients who were born in 1998
and diagnosed before 2005 while resident in England, according to
NRCT records. The remaining 28 matched NRCT cases did not fit
these criteria for the following reasons: two had birth year 1997,
not 1998; three were not residents of England at diagnosis; and 23
did not have a primary diagnosis of leukaemia (7 were non-cancer
and 16 were non-leukaemia cancer). The NRCT contained four
further relevant cases that were apparently not seen as NHS in-
patients while resident in England, and were therefore correctly
not in the HES file.
This cross-check appears to be consistent with a high level of
completeness of ascertainment by the NRCT. Agreement with the
relevant NRCT registrations would require that missing and
inaccurate HES data accounted for the non-matching of some HES
episodes and the matching of some inappropriate NRCT cases, as
described. This does not seem implausible, given the demonstrated
uncertainties of some of the identifying and diagnostic information
in the HES records.
DISCUSSION
Capture-recapture suggests that the NRCT ascertained nearly all
cases of childhood cancer diagnosed during 2003–04 in residents
of Britain. Some of the completeness estimates were slightly
reduced when it was assumed that all CR notifications received
between February 2007 and April 2009 for previously CCLG-only
cases were due to feedback through routine data exchange. Even
under this assumption, however, the completeness estimate was
Table 1 Childhood cancer diagnosed during 2003–2004 in residents of England, Wales and Scotland
Stratification factor Number of registrations (% of total)
by source of notification
Capture-recapture
estimates
Total CR only CCLG only Number of cases Completeness
CR feedback assumption: A B A B A B
Crude 2985 206 (7%) 224 (8%) 117 (4%) 3003.1 2994.1 99% 100%
CR zone of residence P(het)o0.001 P(het)o0.001 P(het)o0.001
Eastern 293 24 (8%) 29 (10%) 28 (10%) 295.9 295.8 99% 99%
Mersey 123 2 (2%) 11 (9%) 10 (8%) 123.2 123.2 100% 100%
North west 218 11 (5%) 13 (6%) 9 (4%) 218.7 218.5 100% 100%
Northern/Yorkshire 325 10 (3%) 21 (6%) 11 (3%) 325.7 325.4 100% 100%
Oxford 157 8 (5%) 4 (3%) 1 (1%) 157.2 157.1 100% 100%
South West 333 24 (7%) 3 (1%) 2 (1%) 333.2 333.2 100% 100%
Thames 559 51 (9%) 103 (18%) 33 (6%) 571.9 562.5 98% 99%
Trent 261 14 (5%) 17 (7%) 10 (4%) 262.0 261.6 100% 100%
West Midlands 294 7 (2%) 7 (2%) 5 (2%) 294.2 294.1 100% 100%
Wales 147 32 (22%) 0 (0%) 0 (0%) 147.0 147.0 100% 100%
Scotland 275 23 (8%) 16 (6%) 8 (3%) 276.6 275.8 99% 100%
Stratified 3005.7 2994.0 99% 100%
Age at diagnosis (years) P(het)o0.001 P(het)¼0.012 P(het)¼0.325
Under 1 305 22 (7%) 38 (12%) 15 (5%) 308.4 306.2 99% 100%
1–4 995 38 (4%) 73 (7%) 38 (4%) 998.1 996.6 100% 100%
5–9 807 49 (6%) 56 (7%) 37 (5%) 810.9 809.5 100% 100%
10–14 878 97 (11%) 57 (6%) 27 (3%) 885.6 881.5 99% 100%
Stratified 3003.1 2993.8 99% 100%
Diagnostic group P(het)o0.001 P(het)¼0.036 P(het)¼0.245
Leukaemia 960 30 (3%) 77 (8%) 35 (4%) 962.7 961.2 100% 100%
Lymphoma 271 16 (6%) 22 (8%) 10 (4%) 272.5 271.7 99% 100%
CNS tumours 733 58 (8%) 41 (6%) 26 (4%) 736.7 735.3 99% 100%
Neuroblastoma 185 6 (3%) 17 (9%) 7 (4%) 185.6 185.2 100% 100%
Retinoblastoma 83 2 (2%) 14 (17%) 9 (11%) 83.4 83.3 100% 100%
Renal cancer 172 3 (2%) 14 (8%) 8 (5%) 172.3 172.2 100% 100%
Hepatic cancer 34 0 (0%) 0 (0%) 0 (0%) 34.0 34.0 100% 100%
Bone cancer 132 9 (7%) 11 (8%) 8 (6%) 132.9 132.6 99% 100%
Soft-tissue sarcoma 217 20 (9%) 11 (5%) 5 (2%) 218.2 217.5 99% 100%
Germ cell/gonadal 98 14 (14%) 12 (12%) 6 (6%) 100.3 99.1 98% 99%
Melanoma/carcinoma 77 30 (39%) 4 (5%) 2 (3%) 79.7 78.3 97% 98%
Other/unspecified cancer 23 18 (78%) 1 (4%) 1 (4%) 26.6 26.6 86% 86%
Stratified 3004.9 2996.9 99% 100%
Known to have died? P(het)¼0.029 P(het)o0.001 P(het)¼0.005
No 2332 173 (7%) 194 (8%) 103 (4%) 2349.1 2340.7 99% 100%
Yes 653 33 (5%) 30 (5%) 14 (2%) 654.7 653.8 100% 100%
Stratified 3003.8 2994.4 99% 100%
Abbreviations: A¼all late CR notifications were feedback; B¼none was; CCLG¼Children’s Cancer and Leukaemia Group; CNS¼intracranial and intraspinal (central nervous
system); CR¼general cancer registry; P(het)¼result of test for heterogeneity between categories.
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probability of ascertainment made almost no difference to the
overall estimate.
The capture-recapture estimates must be interpreted with
caution, because there was undoubtedly some dependence between
the two sources. There may have been direct transfer of data to
some individual CRs from their local CCLG clinical centres before
the NRCT was notified. More generally, both sources use records
from NHS cancer treatment centres, and both might tend to
miss patients with non-fatal disease treated by clinicians not
specialising in oncology.
Although the HES cross-check did not find convincing evidence
of a serious failure of registration by the NRCT, we cannot be
certain without further enquiries that no relevant cases were
missed. Moreover, HES data are clearly not independent of other
hospital-based sources of notification; in particular, the cross-
check could not detect any unregistered children who were treated
by non-NHS clinicians, or were diagnosed only around the time of
death. Recent completeness of ascertainment for early-childhood
leukaemia in residents of England may not be typical of other
periods, ages and diagnostic groups, or of Britain in general.
It is clear that direct notification to the NRCT from specialist
clinicians was a valuable supplement to the general cancer
registration system. Of the 2985 patients known to the NRCT
who were resident in Britain and diagnosed during 2003–2004, the
CRs notified between 92% and 96% overall (depending on the
feedback assumption), and no more than 90% in at least one
region. Overall, the CCLG notified a similar percentage of
registrations (93%).
During 1972–73 in the region of North West England covered
by the Manchester Children’s Tumour Registry (MCTR), 91% of
known childhood cancer cases were ascertained to the MCTR from
Hospital Activity Analysis records (a predecessor of HES), 93%
from the regional CR, and 93% from clinicians; 98–99% could
have been ascertained from any two of these three sources (Leck
et al, 1976). The percentages notified by CR and clinicians seem
remarkably similar to those reported here for national registration
in Britain 30 years later.
A previous two-source capture-recapture study (Draper et al,
1991) estimated NRCT completeness to be 99% for childhood
leukaemia and non-Hodgkin lymphoma in Britain diagnosed
during 1966–83. Although the result resembles the estimates for
leukaemia and lymphoma presented here, the assumption of
independence was more questionable in the earlier study. In
particular, the two sources of ascertainment were defined so that
one source included notification from CRs whereas the other
Table 2 Childhood cancer diagnosed during 2003–2004 in residents of England and Wales
Diagnostic group
Deprivation category
Number of registrations (% of total)
by source of notification
Capture-recapture
estimates
Total CR only CCLG only Number of cases Completeness
CR feedback assumption: A B A B A B
Lymphoid leukaemia P(trend)¼0.341 P(trend)¼0.021 P(trend)¼0.566
1¼least deprived 141 4 (3%) 11 (8%) 7 (5%) 141.4 141.2 100% 100%
2 150 2 (1%) 12 (8%) 7 (5%) 150.2 150.1 100% 100%
3 128 1 (1%) 8 (6%) 2 (2%) 128.1 128.0 100% 100%
4 117 1 (1%) 12 (10%) 3 (3%) 117.1 117.0 100% 100%
5¼most deprived 131 2 (2%) 21 (16%) 10 (8%) 131.4 131.2 100% 100%
Stratified 668.1 667.5 100% 100%
Crude 667 10 (1%) 64 (10%) 29 (4%) 668.1 667.5 100% 100%
Leukaemia P(trend)¼0.064 P(trend)¼0.007 P(trend)¼0.487
1¼least deprived 182 10 (5%) 13 (7%) 8 (4%) 182.8 182.5 100% 100%
2 193 5 (3%) 13 (7%) 8 (4%) 193.4 193.2 100% 100%
3 168 4 (2%) 12 (7%) 4 (2%) 168.3 168.1 100% 100%
4 158 4 (3%) 13 (8%) 3 (2%) 158.4 158.1 100% 100%
5¼most deprived 166 3 (2%) 26 (16%) 12 (7%) 166.6 166.2 100% 100%
Stratified 869.4 868.1 100% 100%
Crude 867 26 (3%) 77 (9%) 35 (4%) 869.6 868.1 100% 100%
CNS tumours P(trend)¼0.035 P(trend)¼0.206 P(trend)¼0.176
1¼least deprived 134 12 (9%) 6 (4%) 5 (4%) 134.6 134.5 100% 100%
2 147 14 (10%) 6 (4%) 3 (2%) 147.7 147.3 100% 100%
3 141 9 (6%) 3 (2%) 3 (2%) 141.2 141.2 100% 100%
4 133 11 (8%) 5 (4%) 4 (3%) 133.5 133.4 100% 100%
5¼most deprived 115 2 (2%) 10 (9%) 8 (7%) 115.2 115.2 100% 100%
Stratified 672.1 671.6 100% 100%
Crude 670 48 (7%) 30 (4%) 23 (3%) 672.4 671.8 100% 100%
Non-CNS solid cancer P(trend)¼0.858 P(trend)¼0.072 P(trend)¼0.277
1¼least deprived 242 18 (7%) 19 (8%) 12 (5%) 243.7 243.0 99% 100%
2 213 26 (12%) 12 (6%) 6 (3%) 214.8 213.9 99% 100%
3 220 17 (8%) 21 (10%) 9 (4%) 222.0 220.8 99% 100%
4 250 32 (13%) 19 (8%) 5 (2%) 253.0 250.8 99% 100%
5¼most deprived 248 16 (6%) 30 (12%) 19 (8%) 250.4 249.4 99% 99%
Stratified 1183.8 1177.8 99% 100%
Crude 1173 109 (9%) 101 (9%) 51 (4%) 1184.4 1178.5 99% 100%
Abbreviations: A¼all late CR notifications were feedback; B¼none was; CCLG¼Children’s Cancer and Leukaemia Group; CNS¼intracranial and intraspinal (central nervous
system); CR¼general cancer registry; P(trend)¼result of test for trend over categories.
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early 1970s, death certificates were an important component of
non-CR ascertainment of leukaemia to the NRCT, and death
certificates have always been a source of ascertainment to the CRs.
Evidence from one region suggested a rather lower level of
completeness during 1972–1984: a cross-check with clinical
records found that 137 (95%) of 144 childhood leukaemia patients
treated at hospitals in the Oxford region had been ascertained by
the NRCT (Draper et al, 1989).
In New Zealand, for the diagnosis period 1990–93, three
different sources of ascertainment notified, respectively, 97%,
98% and 86% of known cases of childhood cancer, with an overall
capture-recapture estimate of nearly 100% (Dockerty et al, 1997).
In three cities in Brazil, for childhood acute leukaemia diagnosed
in 2001, there were 55, 44 and 28 known cases, respectively; overall,
48% were notified by CRs and 60% by a diagnostic laboratory
database (Azevedo-Silva et al, 2009). Two-source capture-recap-
ture estimates for the true numbers of cases in the three cities were
71, 82 and 89, implying relatively low completeness estimates of
77%, 54% and 31%, consistent with the difficulties of cancer
registration in a huge and developing country.
In the present study, as far as possible, univariate stratified
analysis was used to assess and allow for potential dependence
between sources. This is equivalent to fitting a log-linear capture-
recapture model with a single categorical covariate (Tilling et al,
2001). Analysis was also stratified by SES within diagnostic group
and within age group. As there was very little evidence of variation
in completeness with any of the factors considered, we chose
not to apply the more sophisticated modelling methods that are
appropriate for the joint effects of several categorical covariates, or
for continuous covariates (Tilling and Sterne, 1999).
The proportion of registrations notified by the CCLG was very
high (97% or more) for the typical cancers of infancy and early
childhood normally diagnosed in specialist paediatric oncology
centres (leukaemia, neuroblastoma, retinoblastoma, and renal and
hepatic cancers), and rather lower in diagnostic groups that are
relatively frequent in older children, teenagers and adults.
Accordingly, the proportion notified by the CCLG was slightly
lower at ages 10–14 years than in younger age groups. In contrast,
the proportion notified by the CRs was lower for infants than for
older children under one of the feedback assumptions (and may
have been as low as 83% for retinoblastoma).
Both sources notified slightly higher proportions of registrations
for patients who died than for other patients. This is consistent
with the possibility that registration might be slightly more
complete for patients with more aggressive cancers (because they
Table 3 Childhood lymphoid leukaemia diagnosed during 2003–2004 in residents of England and Wales
Age at diagnosis
Deprivation category
Number of registrations (% of total)
by source of notification
Capture-recapture
estimates
Total CR only CCLG only Number of cases Completeness
CR feedback assumption: A B A B A B
Age under 1 year —— —
1¼least deprived 5 0 (0%) 0 (0%) 0 (0%) 5.0 5.0 100% 100%
2 6 1 (17%) 0 (0%) 0 (0%) 6.0 6.0 100% 100%
3 4 0 (0%) 0 (0%) 0 (0%) 4.0 4.0 100% 100%
4 11 0 (0%) 3 (27%) 0 (0%) 11.0 11.0 100% 100%
5¼most deprived 5 1 (20%) 0 (0%) 0 (0%) 5.0 5.0 100% 100%
Stratified 31.0 31.0 100% 100%
Crude 31 2 (6%) 3 (10%) 0 (0%) 31.2 31.0 99% 100%
Age 1–4 years — P(trend)¼0.068 P(trend)¼0.674
1¼least deprived 62 2 (3%) 5 (8%) 5 (8%) 62.2 62.2 100% 100%
2 78 1 (1%) 6 (8%) 4 (5%) 78.1 78.1 100% 100%
3 67 1 (1%) 4 (6%) 0 (0%) 67.1 67.0 100% 100%
4 57 1 (2%) 7 (12%) 2 (4%) 57.1 57.0 100% 100%
5¼most deprived 76 1 (1%) 12 (16%) 5 (7%) 76.2 76.1 100% 100%
Stratified 340.7 340.3 100% 100%
Crude 340 6 (2%) 34 (10%) 16 (5%) 340.7 340.3 100% 100%
Age 5–9 years — P(trend)¼0.658 -
1¼least deprived 49 0 (0%) 2 (4%) 0 (0%) 49.0 49.0 100% 100%
2 39 0 (0%) 4 (10%) 2 (5%) 39.0 39.0 100% 100%
3 38 0 (0%) 2 (5%) 1 (3%) 38.0 38.0 100% 100%
4 31 0 (0%) 1 (3%) 1 (3%) 31.0 31.0 100% 100%
5¼most deprived 29 0 (0%) 3 (10%) 2 (7%) 29.0 29.0 100% 100%
Stratified 186.0 186.0 100% 100%
Crude 186 0 (0%) 12 (6%) 6 (3%) 186.0 186.0 100% 100%
Age 10–14 years — P(trend)¼0.305 —
1¼least deprived 25 2 (8%) 4 (16%) 2 (8%) 25.4 25.2 98% 99%
2 27 0 (0%) 2 (7%) 1 (4%) 27.0 27.0 100% 100%
3 19 0 (0%) 2 (11%) 1 (5%) 19.0 19.0 100% 100%
4 18 0 (0%) 1 (6%) 0 (0%) 18.0 18.0 100% 100%
5¼most deprived 21 0 (0%) 6 (29%) 3 (14%) 21.0 21.0 100% 100%
Stratified 110.4 110.2 100% 100%
Crude 110 2 (2%) 15 (14%) 7 (6%) 110.3 110.1 100% 100%
Abbreviations: A¼all late CR notifications were feedback; B¼none was; CCLG¼Children’s Cancer and Leukaemia Group; CR¼general cancer registry; P(trend)¼result of
test for trend over deprivation categories, for age groups with at least 10 relevant notifications.
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who die (because the death certificate is a source of notification to
the CRs).
For leukaemia and lymphoid leukaemia registrations
from England and Wales, under one of the two feedback
assumptions only, the proportion of CCLG-only notifications
increased with deprivation. There was a contrary trend in CR-only
notification for CNS tumours, suggesting that in deprived
communities a higher proportion of registered cases had been
referred to CCLG centres. A slight deficit of CR notifications from
deprived communities is a possible explanation for both types of
trend.
As described, notification patterns varied slightly according to
geographical area, diagnostic group, age at diagnosis, whether the
patient had died, and (for CNS tumours and perhaps leukaemia)
SES. However, effects on completeness were trivial, because the
great majority of registrations were notified by both sources. The
capture-recapture estimate was 99–100% in almost every sub-
group; it was slightly lower in the Thames region (98–99%), and
in two diagnostic groups that are relatively rare in children
(germ-cell/gonadal cancer 98–99%, melanoma and non-skin
carcinoma 97–98%). There was very little evidence that complete-
ness varied according to age at diagnosis, or whether the patient
had died. There was no evidence that ascertainment was
appreciably less complete in deprived areas of England and Wales
than in affluent areas.
CONCLUSIONS
Of cases of childhood cancer in Britain diagnosed during 2003–04
and registered by the NRCT, 92–96% were notified by general cancer
registries, and 93% by specialist clinicians. Assuming that these
sources were independent, capture-recapture suggests that ascertain-
ment was 99–100% complete. Stratification by various factors that
might affect the probability of notification made no difference to the
completeness estimate. As both sources used records from
treatment centres, the independence assumption cannot be fully
justified. With this caveat, ascertainment of recently diagnosed
childhood cancer in Britain appears to be virtually complete.
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